Kepos Capital LP Takeda Pharmaceutical CO LTD Transaction History

Kepos Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$16.7 - $21.52 $1.25 Million - $1.61 Million	-75,000 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$15.64 - $21.1 $1.17 Million - $1.58 Million	-75,000 Reduced 50.0%	75,000 $1.26 Million
Q3 2018 Nov 13, 2018	BUY	$19.54 - $21.81 $2.54 Million - $2.84 Million	130,000 Added 650.0%	150,000 $3.21 Million
Q2 2018 Aug 13, 2018	BUY	$18.98 - $24.95 $379,600 - $499,000	20,000 New	20,000 $418,000

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.